Anúncio
Anúncio
KRYS
Krystal Biotech, Inc. Common Stock
246.49
USDPatrocinado
-0.05
-0.02%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
246.50
+0.01
0.00%
Relatórios de Lucros KRYS
Rácio de surpresa positiva
KRYS separação 18 de 33 últimas estimativas.
55%
Próximo Relatório
Data do Próximo Relatório
17 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$107.54M
/$1.29
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+9.96%
/-51.50%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+18.00%
/-15.13%
Krystal Biotech, Inc. Common Stock earnings per share and revenue
On 03 de nov. de 2025, KRYS reported earnings of 2.66 USD per share (EPS) for Q3 25, beating the estimate of 1.10 USD, resulting in a 140.22% surprise. Revenue reached 97.80 milhão, compared to an expected 95.05 milhão, with a 2.89% difference. The market reacted with a +0.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of 1.29 USD, with revenue projected to reach 107.54 milhão USD, implying an diminuir of -51.50% EPS, and aumentar of 9.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Krystal Biotech, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Krystal Biotech, Inc. Common Stock reported EPS of $2.66, beating estimates by 140.22%, and revenue of $97.80M, 2.89% above expectations.
How did the market react to Krystal Biotech, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.17%, changed from $197.51 before the earnings release to $197.85 the day after.
When is Krystal Biotech, Inc. Common Stock expected to report next?
The next earning report is scheduled for 17 de fev. de 2026.
What are the forecasts for Krystal Biotech, Inc. Common Stock's next earnings report?
Based on 12
analistas, Krystal Biotech, Inc. Common Stock is expected to report EPS of $1.29 and revenue of $107.54M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio